What USP standards are relevant to sterile compounding, and why are they critical for patient safety?

• A. USP <800> only; governs handling of hazardous drugs but not sterile techniques.
• B. USP <71> deals with compounding quality assurance.
• C. USP <1191> about analytical procedures.
• D. USP <797> and related guidance; they ensure aseptic technique, controlled environments, garbing, and quality testing to prevent contamination.

Answer: (D)

Focusing on creating and maintaining a sterile environment and technique that prevents contamination during compounding, the standards most relevant are USP <797> and related guidance. USP <797> provides a comprehensive framework for sterile compounding, including how the facility should be designed and controlled (air quality and cleaning practices), how personnel should garb and perform hand hygiene, the proper aseptic technique, validated compounding procedures, and a robust quality assurance program with appropriate beyond-use dating and documentation. Following these requirements minimizes the risk of introducing microorganisms, particulates, or endotoxins into sterile preparations, which can cause severe infections, sepsis, or treatment failure in patients.

USP <800> is important for handling hazardous drugs and intersects with sterile compounding, but the direct, primary standard for producing sterile preparations is <797>. Other chapters referenced in the choices address areas such as sterility testing or analytical procedures, which are related to quality and validation but do not define the core framework for aseptic preparation and environmental controls in sterile compounding as <797> does.